MD
Assistant Professor, McGill University
Dr. Ludivine Chamard-Witkowski is a neurologist who recently joined the MCSA after nearly nine years of clinical and research activity in Canada. Over the years, she has developed recognized expertise in early-onset neurocognitive disorders and multiple sclerosis.
She completed her medical training at the Faculty of Medicine in Lyon (France), followed by a residency in neurology. Early in her career, she specialized in rare genetic forms of Alzheimer’s Disease, particularly autosomal dominant Alzheimer’s, which she explored in depth during her fellowship.
After arriving in Canada in 2017, she held a clinician-scientist position in New Brunswick, where she was able to pursue her dual interests in young-onset neurocognitive disorders and inflammatory diseases of the central nervous system. Notably, she founded the first dedicated clinic for early-onset dementia in New Brunswick—a pioneering initiative that addressed previously unmet clinical needs in the province.
Her research has focused on biomarkers in Alzheimer’s Disease, physical and cognitive rehabilitation in mild neurocognitive disorders, and cognitive issues related to long COVID. Her approach closely integrates clinical care and research, with a constant aim to improve patient pathways. She has also initiated several therapeutic clinical trials in both Alzheimer’s Disease and multiple sclerosis. She is the author or co-author of over 45 scientific publications.
“To me, research and clinical practice are inseparable. Being in close contact with patients helps me identify real-world needs and develop innovative, tailored solutions. That’s why I feel so fortunate to be joining a team like the one at MCSA!”